View of EPIDEMIC OF RHEUMATIC HEART DISEASE (RHD): A COST-BENEFIT MODEL COMPARING INVESTMENT IN PRIMARY PREVENTION (PENICILLIN FOR STREP THROAT) VERSUS BUILDING SURGICAL CAPACITY FOR VALVE REPAIR/REPLACEMENT IN A SPECIFIC LMIC REGION

Return to Article Details EPIDEMIC OF RHEUMATIC HEART DISEASE (RHD): A COST-BENEFIT MODEL COMPARING INVESTMENT IN PRIMARY PREVENTION (PENICILLIN FOR STREP THROAT) VERSUS BUILDING SURGICAL CAPACITY FOR VALVE REPAIR/REPLACEMENT IN A SPECIFIC LMIC REGION Download Download PDF